NATALIE GREER: Open Payments
NPI 1801450002 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$408 in 18 payments from 11 companies in 2025. Trend: 2023 $210 · 2024 $1,972 · 2025 $408
Food & beverage: $408
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 3 | $61 |
| Saluda Medical Americas, Inc. | 2 | $57 |
| ABBVIE INC. | 2 | $47 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $46 |
| Lilly USA, LLC | 2 | $38 |
| Pacira Pharmaceuticals Incorporated | 2 | $38 |
| BIOTRONIK NRO, Inc. | 1 | $30 |
| Baxter Healthcare | 1 | $30 |
| Curonix LLC | 1 | $22 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
Products named: Evoke, JOURNAVX, BOTOX, Prospera, TISSEEL, PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A, XTAMPZA, Nucynta.
Industry payments across TX — which companies pay providers there.
